These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19418558)

  • 21. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
    Zhang C; Li L; Hou S; Shi Z; Xu W; Wang Q; He Y; Gong Y; Fang Z; Yang Y
    J Ethnopharmacol; 2021 Oct; 279():114350. PubMed ID: 34157326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells.
    Matsuzaki K
    Cell Tissue Res; 2012 Jan; 347(1):225-43. PubMed ID: 21626291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.
    Yamagata H; Matsuzaki K; Mori S; Yoshida K; Tahashi Y; Furukawa F; Sekimoto G; Watanabe T; Uemura Y; Sakaida N; Yoshioka K; Kamiyama Y; Seki T; Okazaki K
    Cancer Res; 2005 Jan; 65(1):157-65. PubMed ID: 15665291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury.
    Yoshida K; Matsuzaki K; Mori S; Tahashi Y; Yamagata H; Furukawa F; Seki T; Nishizawa M; Fujisawa J; Okazaki K
    Am J Pathol; 2005 Apr; 166(4):1029-39. PubMed ID: 15793284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of TGF-beta signaling during progression of chronic liver diseases.
    Matsuzaki K
    Front Biosci (Landmark Ed); 2009 Jan; 14(8):2923-34. PubMed ID: 19273245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C.
    Yamaguchi T; Matsuzaki K; Inokuchi R; Kawamura R; Yoshida K; Murata M; Fujisawa J; Fukushima N; Sata M; Kage M; Nakashima O; Tamori A; Kawada N; Tsuneyama K; Dooley S; Seki T; Okazaki K
    Hepatol Res; 2013 Dec; 43(12):1327-42. PubMed ID: 23458062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling.
    Hu X; Rui W; Wu C; He S; Jiang J; Zhang X; Yang Y
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1284-91. PubMed ID: 24329763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astragaloside IV suppresses migration and invasion of TGF-β
    Li L; Wang Q; He Y; Sun L; Yang Y; Pang X
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):397-405. PubMed ID: 35092472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma.
    Wang JY; Fang M; Boye A; Wu C; Wu JJ; Ma Y; Hou S; Kan Y; Yang Y
    Oncotarget; 2017 Oct; 8(49):84958-84973. PubMed ID: 29156696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions.
    Yoshida K; Murata M; Yamaguchi T; Matsuzaki K; Okazaki K
    J Clin Med; 2016 Jan; 5(1):. PubMed ID: 26771649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells.
    Liu Q; Mao H; Nie J; Chen W; Yang Q; Dong X; Yu X
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S88-95. PubMed ID: 18552272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGF-beta during human colorectal carcinogenesis: the shift from epithelial to mesenchymal signaling.
    Matsuzaki K; Seki T; Okazaki K
    Inflammopharmacology; 2006 Dec; 14(5-6):198-203. PubMed ID: 17093904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.
    Yamaguchi T; Yoshida K; Murata M; Matsuzaki K
    World J Gastroenterol; 2014 Sep; 20(35):12381-90. PubMed ID: 25253939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echographic detection of diethylnitrosamine-induced liver tumors in rats and the effect of the intratumoral injection of an inhibitor of c-Jun N-terminal kinase.
    Hanajiri K; Mitsui H; Maruyama T; Hashimoto N; Sata M; Omata M
    J Gastroenterol Hepatol; 2009 May; 24(5):866-71. PubMed ID: 19220657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients.
    Nakamura N; Yoshida K; Tsuda R; Murata M; Yamaguchi T; Suwa K; Ichimura M; Tsuneyama K; Matsuzaki K; Nakano T; Hirohara J; Seki T; Okazaki K; Gershwin ME; Naganuma M
    Front Biosci (Landmark Ed); 2021 Dec; 26(12):1480-1492. PubMed ID: 34994163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma.
    Wang J; Ni WH; Hu KB; Zhai XY; Xie F; Jie J; Zhang NN; Jiang LN; Yuan HY; Tai GX
    Cancer Sci; 2017 Mar; 108(3):504-511. PubMed ID: 28012230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest.
    Kuntzen C; Sonuc N; De Toni EN; Opelz C; Mucha SR; Gerbes AL; Eichhorst ST
    Cancer Res; 2005 Aug; 65(15):6780-8. PubMed ID: 16061660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JNK inhibitor SP600125 enhances TGF-β-induced apoptosis of RBE human cholangiocarcinoma cells in a Smad-dependent manner.
    Lin Y; Zhang B; Liang H; Lu Y; Ai X; Zhang B; Chen X
    Mol Med Rep; 2013 Dec; 8(6):1623-9. PubMed ID: 24100678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
    Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
    Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.